Skip to main content

Biocryst Pharmaceuticals Inc

BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000882796

No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.

Holders of 5% or more of BCRX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biocryst Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of BCRX
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A8.40%17.5M shares–Apr 17, 20251 filingApr 17, 2025SEC
Flynn James E13G/A6.81%14.3M shares+1.01 ppfrom 5.80%Sep 19, 20252 filingsFeb 12, 2026SEC
Ra Capital Management, L.P.13G/A6.20%15.8M shares−1.10 ppfrom 7.30%Nov 12, 20252 filingsAug 14, 2026SEC
Vanguard Capital Management LLC13G5.16%13.0M sharesNewApr 29, 20261 filingApr 29, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

40 Schedule 13D and 13G filings on Biocryst Pharmaceuticals Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BCRX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 10, 20266:38 AM ETState Street Corp13G4.80%12.3M shares−1.20 ppfrom 6.00%Below 5%Sep 30, 2026SEC
Aug 14, 20264:39 PM ETRa Capital Management, L.P.and 3 others13G/A6.20%15.8M shares−1.10 ppfrom 7.30%Jun 30, 2026SEC
Aug 7, 20268:48 AM ETState Street Corp13G6.00%15.2M shares+1.10 ppfrom 4.90%Jun 30, 2026SEC
May 12, 20269:59 AM ETState Street Corp13G4.90%12.2M shares−0.40 ppfrom 5.30%Below 5%Mar 31, 2026SEC
Apr 29, 20265:02 PM ETVanguard Capital Management LLC13G5.16%13.0M sharesNewMar 31, 2026SEC
Mar 26, 20264:09 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Feb 12, 20262:17 PM ETFlynn James Eand 3 others13G/A6.81%14.3M shares+1.01 ppfrom 5.80%Dec 31, 2025SEC
Feb 9, 20266:19 AM ETState Street Corp13G5.30%11.1M shares–Dec 31, 2025SEC
Nov 12, 20258:27 PM ETRa Capital Management, L.P.and 3 others13G7.30%15.3M sharesNewNov 4, 2025SEC
Sep 19, 202512:23 PM ETFlynn James Eand 3 others13G5.80%12.2M sharesNewSep 12, 2025SEC
May 15, 20259:31 AM ETAvoro Capital Advisors LLCand 1 other13G/A4.20%8.70M shares–Below 5%Mar 31, 2025SEC
Apr 17, 20259:35 AM ETBlackRock, Inc.13G/A8.40%17.5M shares–Mar 31, 2025SEC
Nov 7, 2024Vanguard Group Inc13G/AOld format–––SEC
Nov 7, 2024Vanguard Group Inc13G/AOld format–––SEC
Nov 4, 2024Vanguard Group Inc13G/AOld format–––SEC
Oct 17, 2024State Street Corp13G/AOld format–––SEC
Sep 10, 202412:09 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 14, 2024Baker Bros. Advisors LP13G/AOld format–––SEC
Feb 14, 2024Avoro Capital Advisors LLC13GOld format–New–SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Jan 24, 20245:23 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 24, 2024State Street Corp13G/AOld format–––SEC
Feb 14, 2023Baker Bros. Advisors LP13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 6, 2023State Street Corp13G/AOld format–––SEC
Feb 3, 20234:27 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 14, 2022Baker Bros. Advisors LP13G/AOld format–––SEC
Feb 9, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2022State Street Corp13G/AOld format–––SEC
Feb 1, 20225:08 PM ETBlackRock Inc.13G/AOld format–––SEC
Apr 12, 2021State Street Corp13G/AOld format–––SEC
Feb 16, 2021Baker Bros. Advisors LP13G/AOld format–––SEC
Feb 16, 2021Citadel Advisors LLC13G/AOld format–––SEC
Feb 16, 2021Point72 Asset Management, L.P.13G/AOld format–––SEC
Feb 11, 2021Janus Henderson Group PLC13G/AOld format–––SEC
Feb 10, 2021Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 5, 2021State Street Corp13GOld format–New–SEC
Jan 28, 20215:56 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 25, 2021Sarissa Capital Management LP13GOld format–New–SEC

Form 144: proposed insider sales

20 notices from officers, directors and other affiliates planning to sell Biocryst Pharmaceuticals Inc shares, newest first.

Form 144 notices for BCRX
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
May 18, 20264:48 PM ETAmy McKeeDirector11.2K$99.9KMay 18, 2026Merrill LynchSEC
May 13, 20261:06 PM ETBarnes Alane POfficer62.5K$596.3KMay 13, 202610b5-1Fidelity Brokerage Services LLCSEC
Mar 20, 202611:36 AM ETHeggie TheresaDirector49.9K$504.6KMar 20, 2026Fidelity Brokerage Services LLCSEC
Mar 16, 20264:17 PM ETBarnes Alane POfficer150.0K$1.37MMar 16, 202610b5-1Fidelity Brokerage Services LLCSEC
Mar 2, 20263:16 PM ETStonehouse Jon PDirector306.0K$2.65MMar 2, 202610b5-1Fidelity Brokerage Services LLCSEC
Dec 22, 20251:27 PM ETBarnes Alane POfficer21.8K$166.6KDec 22, 202510b5-1Fidelity Brokerage Services LLCSEC
Dec 15, 202510:48 AM ETBarnes Alane POfficer21.2K$162.3KDec 15, 202510b5-1Fidelity Brokerage Services LLCSEC
Dec 3, 20252:01 PM ETBarnes Alane POfficer19.8K$151.2KDec 3, 202510b5-1Fidelity Brokerage Services LLCSEC
Dec 2, 20252:09 PM ETBarnes Alane POfficer50.9K$367.2KDec 2, 2025Fidelity Brokerage Services LLCSEC
Dec 1, 202512:51 PM ETBarnes Alane POfficer91.0K$644.3KDec 1, 202510b5-1Fidelity Brokerage Services LLCSEC
Nov 25, 20254:31 PM ETHelen M ThackrayOfficer48.2K$328.0KNov 25, 2025Merrill LynchSEC
Nov 21, 20254:29 PM ETHelen ThackrayOfficer43.3K$307.7KNov 21, 2025Merrill LynchSEC
Nov 13, 202510:21 AM ETSanders MachelleOfficer9.60K$68.5KNov 13, 202510b5-1Fidelity Brokerage Services LLCSEC
Aug 13, 202512:17 PM ETHeggie TheresaDirector70.0K$595.9KAug 13, 2025Fidelity Brokerage Services LLCSEC
Dec 13, 20244:23 PM ETHutson Nancy JDirector7.00K$52.6KDec 13, 202410b5-1Merrill LynchSEC
Jun 24, 20244:11 PM ETMcKee Amy EDirector8.60K$54.1KJun 24, 2024Merrill LynchSEC
Jun 17, 20244:14 PM ETSanders MachelleDirector4.69K$28.0KJun 17, 2024Merrill LynchSEC
Jun 14, 20244:08 PM ETHeggie TheresaDirector6.70K$40.7KJun 14, 2024Merrill LynchSEC
Jun 15, 202310:19 AM ETSanders MachelleOfficer4.00K$31.8KJun 15, 2023Merrill LynchSEC
Jun 14, 202311:32 AM ETHutson Nancy JOfficer12.9K$104.0KJun 14, 2023Merrill LynchSEC